Rickard Linnskog

A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion

J. Howlin, T. Andersson, V. Sherwood, 2009, Proceedings of the National Academy of Sciences.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression

T. Andersson, C. Prasad, L. Axelsson, 2014, Molecular oncology.

Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion

T. Andersson, Purusottam Mohapatra, C. Prasad, 2016, Oncotarget.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.

Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.

P. Berglund, T. Andersson, K. Leandersson, 2016, Translational research : the journal of laboratory and clinical medicine.

A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion

J. Howlin, T. Andersson, V. Sherwood, 2009, Proceedings of the National Academy of Sciences of the United States of America.